Advertisement
Advertisement
U.S. Markets closed
S&P Futures
4,081.00 -9.00 (-0.22%) Dow Futures
34,096.00 -60.00 (-0.18%) Nasdaq Futures
12,110.00 -42.00 (-0.35%) Russell 2000 Futures
1,935.70 -3.70 (-0.19%) Crude Oil
79.30 +0.43 (+0.55%) Gold
1,943.60 -1.70 (-0.09%)
Claritas Pharmaceuticals, Inc. (CLAZF)
Other OTC - Other OTC Delayed Price. Currency in USD
Follow
At close: 03:39PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 0.0168 |
| Open | 0.0130 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0168 - 0.0168 |
| 52 Week Range | 0.0039 - 0.1900 |
| Volume | |
| Avg. Volume | 4,515 |
| Market Cap | N/A |
| Beta (5Y Monthly) | 2.60 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Claritas Announces Approval from OTC to Up-List to OTCQB
SAN FRANCISCO, CA and TORONTO, ON, April 07, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the "Company" or "Claritas") is pleased to announce that it has obtained approval from the OTC Markets Group for listing of its Common Shares on the OTCQB. The Company will provide an update regarding the exact date on which its Common Shares will begin trading on the OTCQB under the ticker symbol "CLAZF". Highlights Claritas has received approval from
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
